Costimulatory connections: CARMIL2 and CD28.

Area of Science:

• Immunology
• Molecular Biology
• Cellular Signaling

Background:

• CD28 is a crucial co-stimulatory receptor in T cell activation.
• NF-κB signaling is essential for T cell function and immune responses.
• CARMIL2 mutations have been linked to immune system dysfunction.

Purpose of the Study:

• To investigate the functional consequences of a gain-of-function mutation in CARMIL2.
• To determine if CARMIL2 can compensate for CD28 deficiency in T cells.
• To explore the impact of CARMIL2 mutations on anti-tumor immunity.

Main Methods:

• Utilized genetic models to study CARMIL2 gain-of-function mutations.
• Assessed NF-κB activation and downstream signaling pathways in T cells.
• Evaluated T cell responses in the context of anti-tumor immunity.

Main Results:

• A specific CARMIL2 gain-of-function mutation was sufficient to substitute for CD28's role in T cell activation.
• This CARMIL2 mutation restored NF-κB activation and downstream signaling.
• The CARMIL2 mutation enhanced T cell-mediated anti-tumor responses.

Conclusions:

• Gain-of-function mutations in CARMIL2 can functionally replace CD28 in T cells.
• CARMIL2 plays a significant role in regulating T cell signaling and anti-tumor immunity.
• Targeting CARMIL2 may offer novel therapeutic avenues for enhancing anti-tumor responses.